Human Atrial Natriuretic Peptide (ANP) Peptide (OVA)

Este producto es parte de BMPR1A - bone morphogenetic protein receptor type 1A
Human Atrial Natriuretic Peptide (ANP) Peptide (OVA)
442€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
Human Atrial Natriuretic Peptide (ANP) Peptide (OVA)
Category
Proteins and Peptides
Provider
Abbexa
Reference
abx651050
Tested Applications
WB, SDS-PAGE

Description

Atrial Natriuretic Peptide (ANP) Protein (OVA) is a Human protein conjugated to OVA.

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Proteins and Peptides
Immunogen Target
Atrial Natriuretic Peptide (ANP)
Host
Synthetic
Assay Type
Activity: Not tested
Origin
Human
Conjugation
OVA
Expression
Synthetic
Purity
> 90%
Size 1
100 µg
Size 2
200 µg
Size 3
500 µg
Size 4
1 mg
Size 5
5 mg
Form
Lyophilized
Tested Applications
WB, SDS-PAGE
Buffer
Prior to lyophilization: PBS, pH 7.4.
Availability
Shipped within 5-7 working days.
Storage
Store lyophilized form at 2-8°C for up to 1 month. For longer periods, store lyophilized or liquid at -80°C. Avoid repeated freeze–thaw cycles.
Dry Ice
No
Alias
Activin receptor-like kinase 3,ALK3,SKR5,ALK-3,CD292,ACVRLK3,BMPR-1A,Serine/threonine-protein kinase receptor R5
Background
Protein BMPR1A
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
To keep the original salt concentration, we recommend reconstituting to the original concentration prior to lyophilization (see Concentration) in ddH2O. If a lower concentration is required, dilute in PBS, pH 7.4. If a higher concentration is required, the product can be reconstituted directly in PBS, pH 7.4, though please note that this will change the overall salt concentration. The stock concentration should be between 0.1-1.0 mg/ml. Do not vortex.
Concentration: Prior to lyophilization: 200 µg/ml

Background

Bone morphogenetic protein receptor type 1A (BMPR1A) is a receptor for the bone morphogenetic proteins (BMPs), a subgroup of the transforming growth factor-beta (TGF-β) superfamily. BMPs are growth factors and cytokines that play critical roles in embryonic development, skeletal formation, organogenesis, and tissue homeostasis. BMPR1A, also known as ALK3 (Activin receptor-like kinase 3), specifically mediates BMP signaling by interacting with BMP ligands to activate intracellular pathways, influencing processes such as cell growth, differentiation, apoptosis, and repair. This receptor is essential for bone and cartilage development and has critical roles in several cell types across various tissues, with particularly strong influence in skeletal, cardiac, and gastrointestinal systems.

Productos relacionados

abx001501

Bone Morphogenetic Protein Receptor 1A (BMPR1A) Antibody

BMPR1A Antibody is a Rabbit Polyclonal antibody against BMPR1A. The bone morphogenetic protein (BMP) receptors are a fam…

Ver producto
abx015776

Bone Morphogenetic Protein Receptor 1A (BMPR1A) Antibody

The bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the t…

Ver producto
abx015777

Bone Morphogenetic Protein Receptor 1A (BMPR1A) Antibody

The bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the t…

Ver producto